1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Cancer/Tumor Profiling Market by Technology, by Technique, by Application, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

Cancer/Tumor Profiling Market by Technology, by Technique, by Application, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

  • November 2017
  • 161 pages
  • ID: 5289041
  • Format: PDF
  • By Prescient & Strategic Intelligence Private Limited

Summary

Table of Contents

Global cancer/tumor profiling market size is projected to achieve a value of $87.1 billion value by 2023, growing at a CAGR of 19.0% during 2017-2023.

The boost in demand for cancer/tumor profiling products is mainly led by increasing number of new cancer cases, rising utility of biomarkers in tumor profiling, rising availability of funding for cancer research and increasing demand for next generation sequencing for cancer profiling.

Insights on market segments
The cancer profiling market has been bifurcated into next generation sequencing (NGS), quantitative polymerase chain reaction (QPCR), immunohistochemistry (IHC), in-situ hybridization (ISH), and microarray, based on technology. NGS held the largest share in the cancer profiling market, standing at 33.1%, in 2016. This leading position of NGS is mainly characterized by increased awareness about NGS products due to rising promotional activities for these products among the research laboratories and academic institutes. The NGS category is also expected to grow at the highest CAGR during the forecast period.

ISH is further categorized into fluorescent in situ hybridization (FISH) and chromogenic in situ hybridization (CISH). FISH held the larger share of the ISH technology market in 2016. The higher penetration of this technology is driven by increasing number of players offering FISH in cancer profiling market, such as Abbott Laboratories. FISH is also expected to observe the faster growth in future, with the CAGR likely to stand at 18.6% during the forecast period.

The various techniques used in the cancer profiling include genomics, proteomics, epigenetics, and metabolomics. Genomics held the largest share of 40.6% in 2016, and it is also expected to register highest growth during the forecast period, due to increasing implementation of genomic sequencing.

Cancer profiling is used in varied applications such as personalized medicine, diagnostics, biomarker discovery, prognostics, and others. In 2016, personalized medicine held largest share of 36.4% in the cancer profiling market, attributed to subsequent increasing adoption of personalized medicine for tumor profiling, since it is one of the most cost-effective methods. The application is also expected to register fastest growth during the forecast period.

Asia-Pacific is projected to register the fastest growth in cancer/tumor profiling market
The Asia-Pacific cancer profiling market has been experiencing significant growth due to rising prevalence of cancer, increasing government initiatives for cancer treatment, and rising healthcare expenditure in the region.

According to the Indian Council of Medical Research (ICMR), around 14.5 lakhs of new cancer cases were registered in India in 2016, which is likely to reach nearly 17.3 lakh new cases, by 2020. This increase in cancer cases indicates that, the healthcare providers will require more profiling kits, thus increasing the demand for cancer/tumor profiling kits in the region.

Key competitors are introducing new and innovative products cancer/tumor profiling market
Globally, the key providers in the cancer profiling market are launching new products to gain a larger market share. In October 2017, QIAGEN N.V. launched custom solutions business, aimed at providing life sciences and molecular diagnostics companies with the tools and expertise required to quickly build and commercialize products that meet unique workflow requirements. In the same month, the company also launched ipsogen JAK2 RGQ PCR kit, an ipsogen JAK2 assay, an assay used for the detection of the JAK2 V617F/G1849T allele in genomic DNA extracted from EDTA whole blood.

Some of the other key players operating in the cancer profiling market include Illumina, Inc., NeoGenomics Inc., Caris Life Sciences, Inc., Helomics Corp., Oxford Gene Technology, HTG Molecular Diagnostics, Inc., RiboMed Biotechnologies, Inc., Genomic Health, Inc., and NanoString Technologies, Inc.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Oncology Nutrition Industry

Global Oncology Nutrition Industry

  • $ 4950
  • February 2020

Oncology Nutrition market worldwide is projected to grow by US$1.1 Billion, driven by a compounded growth of 8.4%. Head & Neck, one of the segments analyzed and sized in this study, displays the potential ...

Asia Pacific Cancer Tissue Diagnostics Market to 2027 - Regional Analysis and Forecasts By Test Type and Country.

Asia Pacific Cancer Tissue Diagnostics Market to 2027 - Regional Analysis and Forecasts By Test Type and Country.

  • $ 3000
  • January 2020

The Asia Pacific Cancer tissue diagnostics market is expected to reach US$ 730.09 Mn in 2027 from US$ 410.78 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027.The growth of ...

Interleukin 1 - Pipeline Review, H1 2020

Interleukin 1 - Pipeline Review, H1 2020

  • $ 3500
  • January 2020

Interleukin 1 - Pipeline Review, H1 2020SummaryInterleukin 1 (IL1) pipeline Target constitutes close to 24 molecules. Out of which approximately 23 molecules are developed by companies and remaining by ...


ref:plp2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on